Press release
Surging Prevalence Of Rare Diseases Powers Growth Of The Orphan Drugs Market: An Emerging Driver Transforming The Orphan Drugs Market Landscape
Orphan Drugs
What Is the Current Orphan Drugs Market Size and Its Estimated Growth Rate?
The orphan drugs market has seen rapid growth in recent years. It will increase from $188.45 billion in 2024 to $208.04 billion in 2025, at a compound annual growth rate (CAGR) of 10.4%. The growth is driven by the Orphan Drug Act of 1983, growing interest in rare diseases, drug repurposing efforts, advancements in genetic understanding, and increased research funding initiatives.
The orphan drugs market is expected to experience exponential growth, reaching $481.69 billion by 2029 at a CAGR of 23.4%. The market growth will be driven by improved market access policies, value-based healthcare initiatives, global expansion, patient-centric drug development, and a focus on rare cancers. Key trends include target identification, accelerated regulatory pathways, gene therapy advancements, and precision medicine applications.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2823
How Are Emerging Segments Shaping the Orphan Drugs Market Landscape?
The orphan drugs market covered in this report is segmented -
1) By Therapy Area: Oncology, Blood, Central Nervous System, Endocrine, Cardiovascular, Respiratory, Immunomodulatory
2) By Diseases Type: Oncology, Hematology, Neurology, Cardiovascular, Other Disease Types
3) By Drug Type: Biological, Non-Biological
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Sales
Subsegments:
1) By Oncology: Targeted Therapies, Chemotherapy Agents, Immunotherapy Drugs, Hormonal Therapies
2) By Blood: Hematopoietic Growth Factors, Coagulation Factor Concentrates, Treatments for Rare Blood Disorders
3) By Central Nervous System: Medications for Rare Neurological Disorders, Antiepileptic Drugs for Rare Epilepsy Syndromes, Treatments for Rare Neurodegenerative Diseases
4) By Endocrine: Hormonal Replacement Therapies, Treatments for Rare Endocrine Disorders
5) By Cardiovascular: Medications for Rare Cardiovascular Conditions, Treatments for Rare Genetic Heart Disorders
6) By Respiratory: Therapies for Rare Respiratory Diseases, Medications for Rare Allergic Conditions
7) By Immunomodulatory: Treatments for Rare Autoimmune Disorders, Immunotherapies for Rare Inflammatory Conditions
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2823&type=smp
Which Growth Factors Are Influencing Orphan Drugs Market Expansion?
The growth of the orphan drugs market is being driven by the increasing prevalence of rare diseases. Rare diseases are those that affect a small portion of the population, and their treatments often require cold chain logistics, which may not be available in all regions. For example, the American Cancer Society reported in January 2022 that around 54,000 new cases of oral cancer are diagnosed annually in the USA. The growing number of rare diseases worldwide is a key driver for the orphan drugs market.
Who Are the Dominant Players Across Different Orphan Drugs Market Segments?
Major companies operating in the orphan drugs market include Pfizer Inc., Johnson & Johnson Services Inc., F Hoffmann-La Roche Ltd., Farbenfabriken Bayer AG, Novartis AG, Sanofi SA, Bristol-Myers Squibb Co., AstraZeneca plc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Applied Molecular Genetics Inc., Novo Nordisk A/S, Merck & Co. KG, AbbVie Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., CSL Limited, Biogen Inc., Celgene Corporation, Vertex Pharmaceuticals Inc., Eisai Co. Ltd., Grifols SA, Alexion Pharmaceuticals Inc., BioMarin Pharmaceutical Inc., Aegerion Pharmaceuticals Inc., Sankyo Co. Ltd.
What Are the Major Trends Shaping the Orphan Drugs Market?
The approval of biological orphan drugs for multiple indications is a major trend driving the orphan drugs market. Biological orphan drugs are designed to treat rare diseases like cancer with fewer side effects. Cardax, Inc. announced its collaboration with Dr. Frederick D. Sancilio to develop biological orphan drugs for rare diseases, aiming to increase revenue by addressing unmet medical needs.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/orphan-drug-global-market-report
Which Geographic Regions Are Expected to Dominate the Orphan Drugs Market in the Coming Years?
The countries covered in the orphan drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Orphan Drugs Market?
2. What is the CAGR expected in the Orphan Drugs Market?
3. What Are the Key Innovations Transforming the Orphan Drugs Industry?
4. Which Region Is Leading the Orphan Drugs Market?
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Surging Prevalence Of Rare Diseases Powers Growth Of The Orphan Drugs Market: An Emerging Driver Transforming The Orphan Drugs Market Landscape here
News-ID: 4060675 • Views: …
More Releases from The Business Research Company
Trends in Growth, Segment Analysis, and Competitive Strategies Influencing the M …
The meal replacement market is gaining significant momentum as consumer preferences shift toward convenient and health-focused nutrition solutions. With rising awareness about preventive healthcare and personalized diets, this sector is set for considerable expansion. Let's explore how the market size is expected to evolve, who the key players are, emerging trends, and the main segments driving this growth.
Projected Growth Trajectory of the Meal Replacement Market Size
The meal replacement…
Leading Companies Reinforcing Their Presence in the Malted Barley Market
The malted barley industry is positioned for steady expansion as demand grows across various sectors. With increasing interest from craft brewers and functional food producers, this market is set to experience meaningful growth driven by innovation and sustainability efforts. Let's dive into the current market size, key players shaping the industry, trends influencing its trajectory, and detailed segment insights.
Projected Market Size and Growth Outlook of the Malted Barley Market …
Future Perspective: Key Trends Shaping the Low-calorie Food Market up to 2030
The low-calorie food market is poised for significant expansion as consumer preferences shift toward healthier eating habits and more personalized nutrition options. Advances in product innovation and supportive regulatory frameworks are expected to drive rapid growth over the coming years. Here's an overview of the market size, key players, emerging trends, and segmentation shaping this evolving industry.
Projected Expansion of the Low-calorie Food Market Size Through 2030
The low-calorie food…
Competitive Landscape: Leading Companies and New Entrants in the Liquid Nutritio …
The liquid nutritional supplement sector is on the rise, driven by evolving consumer preferences and innovations in health and wellness. With growing awareness about personalized nutrition and preventive healthcare, this market is set to witness substantial growth over the coming years. Let's explore the market's projected size, major players, emerging trends, and key segments shaping this dynamic industry.
Projected Market Value and Growth Trajectory of the Liquid Nutritional Supplement Market …
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
